Retinoic acid, Retinoid RAR agonist (TBI1138)

Description

Product Details

Formal Name: 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2E,4E,6E,8E,-nonatetraenoic acid

Alternate Names: ATRA; Tretinoin

Molecular Formula: C₂₀H₂₈O₂

Formula Weight: 300.44

CAS Number: 302-79-4

Purity: >98%

Formulation: powder

Solubility: Soluble in DMSO (up to 8 mg/ml) or in Ethanol (up to 15 mg/ml).

Storage: -20°C

Stability: ≥ 2 years.

 

Applications

Retinoid RAR agonist

 

Functions

all−trans−Retinoic acid (ATRA; a metabolite of Vitamin A) is an endogenous  ligand for the retinoic acid receptor (RAR). The binding of retinoic acid to the RAR and retinoid X (RXR) heterodimer causes conformation changes in RAR that affects the binding of other proteins that regulate the growth and differentiation of a variety of both normal and malignant cells. ATRA promotes differentiation of embryonic stem cells (ESCs) into a variety of cell types in vitro.

 

Application Procedures

First dissolved in DMSO (up to 8 mg/ml) or in Ethanol (up to 15 mg/ml), then diluted to aqueous buffer. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.

Additional information

SIZE (mg)	500 MG, 50 MG

TBI1138_Retinoic acid